NLRP3 and hepatocellular carcinoma: Regarding all these data, we suggest that after treating HepG2 HCC cells with 17β-estradiol, it binds to and activates ERs which in turn can upregulate the expression of NLRP3 inflammasome components and also can activate the MAPK signaling pathway resulting in phosphorylation of NLRP3 protein.